Thursday, April 16, 2020
Paul has been selected as a recipient of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), 2020 Presidential Trainee Award as recognition for his abstract titled Integration of Ontogeny into PBPK Models for Monoclonal Antibodies in Very Young Children. He was supposed to be presenting his abstract during the annual meeting in March 2020 in Houston, TX, and receiving his special recognition, but due to COVID-19 he was unable to attend.